Mucahit GUNAYDİN, Ali AYGUN, Murat USTA, Abdussamed VURAL, Faruk OZSAHİN

Serum adropin levels in patients with acute ischemic stroke

Stroke is one of the principal diseases leading to death and permanent disability worldwide. One of the main causes of stroke is atherosclerosis. A decrease in Adropin levels has been identified as an independent predictor of atherosclerosis development. The purpose of this study was to determine serum Adropin levels in patients with acute ischemic stroke (AIS) and to investigate the relation between Adropin levels and stroke. Fifty-nine patients presenting to the emergency department with symptoms of stroke and diagnosed with AIS, and 51 healthy individuals representing the control group, were included in the study. Patient and control group demographic data and clinical characteristics were recorded. Serum Adropin levels were studied in blood specimens collected from both groups. The results were then compared. Patient group serum Adropin levels were significantly lower than those of the control group (2.16±0.76, and 2.72±1.01, respectively p=0.002). Multivariate logistic regression analysis identified a low serum Adropin level as an independent predictor of stroke (OR=0.420, 95% Cl=0.221-0.801, p=0.008). We also determined significant inverse correlation between serum Adropin levels and glucose levels (r= -0.345, p=0.013). Our study suggested that, low serum Adropin levels are associated with AIS. Adropin may be used as a screening tool for AIS

PDF

___

1. Khoshnam SE, Winlow W, Farzaneh M, et al. Pathogenic mechanisms following ischemic stroke. Neurol Sci. 2017;38:1167-86

2. Hui C, Tadi P, Patti L. Ischemic Stroke. Updated 2019 Mar 19. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing; 2019 Jan.

3. XH Yu, K Qian, N Jiang, et al. ABCG5/ABCG8 in cholesterol excretion and atherosclerosis. Clin Chim Acta 2014;428:82-8.

4. Titov BV, Matveeva NA, Martynov MY, et al. Ischemic stroke as a complex polygenic disease. Mol Biol (Mosk). 2015;49:224-48.

5. Manzano JJ, De Silva DA, Pascual JL, et al. Associations of ankle-brachial index (ABI) with cerebral arterial disease and vascular events following ischemic stroke. Atherosclerosis. 2012;223:219–22.

6. Kumar KG, Trevaskis JL, Lam DD, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008;8:468–81.

7. Lovren F, Pan Y, Quan A, et al. Adropin is a novel regulator of endothelial function. Circulation. 2010;122:185–92.

8. Kathir K, Adams MR. Endothelial dysfunction as a predictor of acute coronary syndromes. Semin Vasc Med. 2003;3:355–62.

9. Wu L, Fang J, Chen L, et al. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin Chem Lab Med. 2014;52:751–8.

10. Yu HY, Zhao P, Wu MC, et al. Serum adropin levels are decreased in patients with acute myocardial infarction. Regul Pept. 2014;190-191:46-9.

11. Ertem AG, Ünal S, Efe TH, et al. Association between serum adropin level and burden of coronary artery disease in patients with non-ST elevation myocardial infarction. Anatol J Cardiol. 2017;17:119-124.

12. Shahjouei S, Ansari S, Pourmotabbed T, et al. Potential roles of adropin in central nervous system: review of current literature. Front Mol Biosci. 2016;3:25.

13. Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol. 2004;24:413–20.

14. Zhao LP, You T, Chan SP, et al. Adropin is associated with hyperhomocysteine and coronary atherosclerosis. Exp Ther Med. 2016;11:1065-70

15. Yang C, DeMars KM, Hawkins KE, et al. Adropin reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions. Peptides. 2016;81:29-37.

16. Szewczak K, Niespialowska M, Solarska BJ, et al. Prospective of ischemic stroke biomarkers. Curr Issues Pharm Med Sci. 2017;30:69-74.

17. Monbailliu T, Goossens J, Hachimi-Idrissi S. Blood protein biomarkers as diagnostic tool for ischemic stroke: a systematic review. Biomark Med. 2017;11:503-12.

18. Aydin S. Three new players in energy regulation: preptin, adropin and irisin. Peptides. 2014;56:94–110.

19. Butler AA, Tam CS, Stanhope KL, et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab. 2012;97:3783–91.

20. Lian W, Gu X, Qin Y, et al. Elevated plasma levels of adropin in heart failure patients. Intern Med. 2011;50:1523–7.